Key result
Intraoperative hyperglycemia occurred in 20.4% of non-diabetic orthopedic surgery patients and was strongly associated with intraoperative blood transfusion (AOR 6.64), dextrose infusion, hypothermia, and hypertension.
Why the study?
Intraoperative hyperglycemia is common among patients undergoing orthopedic surgery, but its incidence varies widely and has not been clearly studied in developing countries.
What is the magnitude and what are the associated factors of intraoperative hyperglycemia among orthopedic surgical patients?
Cross-Sectional (n=240)
Yes
What is the magnitude and what are the associated factors of intraoperative hyperglycemia among orthopedic surgical patients?
Odds Ratio: 6.64 (95% CI 2.92–15.08)
p-value: p=0.00
Intraoperative hyperglycemia is common (20.4%) during orthopedic surgery and is significantly associated with modifiable factors such as dextrose IV fluid administration, blood transfusion, and hypothermia.
Intraoperative hyperglycemia occurred in 20% of Ethiopian orthopedic cases and was associated with hypothermia, dextrose fluids, transfusion, and hypertension; leaves open whether modifying these factors improves outcomes.
Background: Intraoperative hyperglycemia is a common problem among patients undergoing orthopedic surgery. Its incidence varies from country to country and not clearly studied in developing countries. Method: Multi-center cross-sectional study was conducted on eligible adult elective patients who underwent orthopedic surgical procedures. The participants were selected using a systematic random sampling technique. Data was collected on basic characteristics, medical and surgical history. On the arrival of patients to the OR, blood glucose was measured and recorded and repeated after administering anesthesia. The data was analyzed using descriptive statistics and bivariate and multivariate logistic regression. P<0.05 was considered as statistically significant. Results: Intraoperative hyperglycemia was observed in 20.4% of patients. Hypothermia (AOR:2.45;95% CI:0.97-6.27, p=0.05), infused dextrose iv fluids (AOR:2.94;95% CI:1.64-5.16, p=0.05), blood transfusion (AOR:6.64;95% CI:2.92-15.08, p=0.00) and history of hypertension (AOR:2.19;95% CI:1.23-3.71, p=0.01) were factors identified to be associated with intraoperative hyperglycemia. Conclusions: This study showed the magnitude of intraoperative hyperglycemia was high. Anesthetists should identify all risk factors preoperatively and make appropriate adjustments for patient care. Hypertension should be optimized, refrain from routine administering of dextrose IV fluids, and unnecessary transfusions, as well as monitor patients’ body temperature.
No takes yet. Share an insight, caveat, or question.
Geresu Gebeyehu (2023) conducted a cross-sectional in Orthopedic surgical patients (n=240). Intraoperative blood transfusion vs. No intraoperative blood transfusion was evaluated on Intraoperative hyperglycemia (AOR 6.64, 95% CI 2.92-15.08, p=0.00). Intraoperative hyperglycemia occurred in 20.4% of non-diabetic orthopedic surgery patients and was strongly associated with intraoperative blood transfusion (AOR 6.64), dextrose infusion, hypothermia, and hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: